Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
The Cybersecurity Nightmares Threatening Modern Organizations
Cybersecurity leaders examine the hidden threats facing organizations, from shadow AI and legacy systems to alert fatigue, analyst burnout and emerging AI risks.
17m watch -
Keeping Aging Federal Systems Running Amid OT Vulnerabilities
A techno-thriller novel highlights how organizational silos can become critical infrastructure vulnerabilities in the AI era.
19m watch -
HHS Looks to Centralize IT Buying, Speed Access to Emerging Tech
HHS is centralizing IT procurement while pursuing faster acquisition tools for AI and other emerging technologies.
9m watch -
VA Employees Save 6 Hours a Week With AI Tools
VA AI chief Kimberly McManus said AI tools are helping improve veteran care, reduce opioid overdose mortality and save time for employees.
4m watch
